Understanding the 2019-novel Coronavirus (2019-nCoV) and Coronavirus Disease (COVID-19) Based on Available Evidence - A Review Study

Authors

  • Alishiri, Gholamhossein
  • Farnoosh, Gholamreza
  • Hosseini Zijoud, Seyed Reza
Abstract:

Since December 2019, a new coronavirus, called the 2019-novel coronavirus (2019-nCoV), triggers pneumonia outbreak from Wuhan (Huanan seafood market) across China, which now poses major health threats to public health. The Corona Virus Disease-2019 (COVID-19) epidemic by 2019-nCoV is spreading worldwide, and by March 1, 2020, 67 countries, including Iran, have been affected. According to worldwide statistics, the mortality rate is 3.4%. Early symptoms of COVID-19 include pneumonia, fever, myalgia and fatigue. To date, no successful vaccine or antiviral agents has been clinically approved for COVID-19. Therefore, prevention and control of infection is a top priority for the general public. Extensive research into the 2019-nCoV is needed to fully elucidate its pathway and pathogenic mechanisms, and to identify potential therapeutic targets, which can be effective in developing common preventive and therapeutic measures. In this review study, based on evidences published until March 1, 2020, the epidemic and etiologic features of the 2019-nCoV, its essential biological features, including its receptors and route of transmission, outline disease prevention and treatment approaches is provided. Given the origin of the Covid-19, it seems that the nutritional and health recommendations of Islam, especially Halal food and health observance, need to be addressed more throughout the world. Lack of inducing stress and anxiety among the people, besides advising and training people to abide by all the principles of health, is so important to fight against the disease. It is hoped that Covid-19 prevention, control and treatment will be achieved through vaccine and antiviral agents’ production as well as health care measures in the near future.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Obesity and Coronavirus Disease 2019 (COVID-19)

Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection that was first reported on December 31, 2019 in China . This disease behaves variously: from asymptomatic infection to influenza-like symptoms and severe acute respiratory distress syndrome (ARDS) . In the recent months, COVID-19 has infected millions and killed hundre...

full text

A Review of Coronavirus Disease-2019 (COVID-19)

There is a new public health crises threatening the world with the emergence and spread of 2019 novel coronavirus (2019-nCoV). The virus originated in bats and was transmitted to humans through yet unknown intermediary animals in Wuhan, China in December 2019. The virus spreads faster than its two ancestors the SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), but has lower ...

full text

A Review of Pharmacotherapy for Coronavirus Disease 2019 (COVID-19)

The epidemic of COVID-19 and its associated acute respiratory syndrome has posed an unprecedented challenge in identifying effective drugs to prevent and treat it. Due to the high prevalence of this disease and the high number of people at risk, medical staff needs accurate evidence regarding effective drug treatments for this infection. There is currently no effective treatment for COVID-19. B...

full text

Coronavirus disease 2019 (COVID-19) Immunopathogenesis, Diagnosis, and Treatment

SARS-CoV-2 is a member of the coronaviruses family that causes the outbreak of coronavirus disease 2019 (COVID-19) in China in late 2019 which has exploded to a global pandemic. The reference genome of the SARS-CoV-2 is considered to be very closely related to SARS-CoV and the virus uses the ACE-2 receptor for cellular entry similar to SARS-CoV. The most common symptoms of COVID-19 are fever, c...

full text

Hematology findings in patients with Coronavirus disease 2019 (COVID-19)

In December 2019, Wuhan, the capital of Hubei Province in China, became the center of an outbreak of pneumonia with unknown etiology. By 7 January 2020, Chinese scientists have isolated a new coronavirus from patients with viral infectious pneumonia, the Coronavirus 2 Acute Respiratory Syndrome (SARS-CoV-2), previously called 2019-nCoV. The disease was later diagnosed as coronavirus 2019 (COVID...

full text

Exercise Considerations during Coronavirus Disease 2019 (COVID-19) Outbreak: A Narrative Review

The widespread outbreak of coronavirus (COVID-19) worldwide has raised concerns about physical activity and exercise. A review of research on physical training and viral infections shows that regular, moderate-intensity aerobic exercise (65-80% VO2max) increases antibody titers, lymphocyte proliferation, gamma interferon, immunoglobulin M, G, and natural killer cells production. It modulates th...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 22  issue 1

pages  1- 11

publication date 2020-03

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023